1
STAGNI MARCELLO: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. SOOFT ITALIA, Sarpi Maurizio, March 4, 2010: WO/2010/023705 (9 worldwide citation)

Described herein is the use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by means of the method of corneal cross-linking.


2
Stagni Marcello, Cavallo Giovanni, Biondi Enrico, Iaselli Vincenzo, Sodo Eugenio: Ophthalmic gel made up of triamcinolone acetonide and a polyacrylic polymer. Sooft Italia, May 9, 2007: EP1782795-A1 (2 worldwide citation)

For the preparation of ophthalmic gels containing triamcinolone acetonide as active principle, use is envisaged of gelifying agents, such as homopolymers of acrylic acid cross-linked with an alkyl sucrose or with an alkyl pentaerythritol (carbopol - carbomer). The triamcinolone acetonide gel obtaine ...


3

4
Fulvio Foschini, Pierre Roy, Edoardo Stagni, Giovanni Cavallo, Giulio Luciani: Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus. SOOFT ITALIA, Young & Thompson, July 11, 2017: US09700456

Ocular iontophoresis device and method for delivering any ionized drug solution to the cornea includes: a reservoir containing a solution suitable to be positioned on the eye; an active electrode disposed in or on the reservoir; and a passive electrode suitable to be placed on the skin of the subjec ...


5
BIONDI MARCO , BIONDI PIERO , STAGNI EDOARDO , STAGNI MARCELLO : [de] OPHTHALMISCHE ZUSAMMENSETZUNG MIT INOSITOL ZUR VERBESSERUNG DER VISUELLEN AUFNAHME, [en] OPHTHALMIC COMPOSITION COMPRISING INOSITOL FOR IMPROVING VISUAL ACCOMODATION, [fr] COMPOSITION OPHTALMIQUE COMPRENANT DE LINOSITOL PERMETTANT DAMÉLIORER LADAPTATION VISUELLE. SOOFT ITALIA S P A , February 15, 2017: EP3130335-A1

[en] An ophthalmic composition for topical use comprising myo-inositol, optionally in combination with hypromellose, as a therapeutic agent, for use in the treatment of eye disorders caused by environmental, mechanical and visual stress, including accommodative asthenopia and effort and to prolong t ...


6
Massimo Filippello: Method for prevention of presbyopia and glaucoma, and means for carrying out said treatment. Sooft Italia, Young & Thompson, April 21, 2015: US09014812

A method of for prevention of presbyopia and glaucoma envisages stimulation of the ciliary body to determine contraction thereof via a low-voltage d.c. current sent in the form of pulse trains. This contraction, if applied in a rhythmic way at a constant frequency, subjects the ciliary muscle to a p ...


7
Fulvio Foschini, Marcello Stagni, Giulio Luciani, Pierre Roy: Cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus. SOOFT ITALIA, Young & Thompson, September 13, 2016: US09439908

An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the tre ...


8

9
Biondi Catia, Biondi Piero, Biondi Enrico, Biondi Chiara: Alimentary pasta enriched and supplemented with lutein. Sooft Italia, April 2, 2008: EP1903891-A2

Described herein is an alimentary pasta supplemented with lutein usable for the prevention of the deficiency of said element and as adjuvant in the treatment of senile macular degeneration .


10
Marcello STAGNI, Edoardo STAGNI, Massimo FILIPPELLO, Giovanni CAVALLO, Eugenio SODO: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. Sooft Italia, June 23, 2011: US20110152219-A1

The use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by the method of corneal cross-linking.



Click the thumbnails below to visualize the patent trend.